Insider · CIK 0002045943

Abate Kristin

Reports to the SEC for 1 company · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0002045943

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-16	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−4,788 sh	$0.34	−$1,647.072	18,616
2026-10-01	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−378 sh	$1.19	−$449.82	23,404
2026-09-01	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−19 sh	$2.02	−$38.38	23,782
2026-03-02	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−559 sh	$9.41	−$5,259.911	22,063
2026-01-28	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−50 sh	$7.03	−$351.5	22,622
2026-01-27	KPTIKaryopharm Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+92 sh	—	—	22,672
2026-01-21	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−265 sh	$5.96	−$1,579.4	22,580
2025-10-15	KPTIKaryopharm Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+12.8K sh	—	—	22,845
2025-10-01	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−362 sh	$6.30	−$2,279.152	10,046
2025-09-15	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−23 sh	$6.43	−$147.89	10,408
2025-09-12	KPTIKaryopharm Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+46 sh	—	—	10,431
2025-09-03	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−12 sh	$6.78	−$81.36	9,463
2025-07-22	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−238 sh	$4.00	−$952	9,475
2025-03-04	KPTIKaryopharm Therapeutics Inc.S Sale	Chief Accounting Officer	SSale	−571 sh	$6.29	−$3,591.59	9,713
2025-02-28	KPTIKaryopharm Therapeutics Inc.A Award	Chief Accounting Officer	AAward	+933 sh	—	—	10,284
2025-02-28	KPTIKaryopharm Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+1,866 sh	—	—	1,866

Recent filings

Accepted (ET)
Oct 194
Abate Kristin0001193125-26-425227
SEC(opens sec.gov)
Oct 24
Abate Kristin0001193125-26-412209
SEC(opens sec.gov)
Sep 24
Abate Kristin0001193125-26-380404
SEC(opens sec.gov)
Mar 34
Abate Kristin0002045943-26-000003
SEC(opens sec.gov)
Jan 294
Abate Kristin0001193125-26-029599
SEC(opens sec.gov)
Jan 224
Abate Kristin0001193125-26-019428
SEC(opens sec.gov)
Oct 164
Abate Kristin0001193125-25-241487
SEC(opens sec.gov)
Oct 34
Abate Kristin0001193125-25-230359
SEC(opens sec.gov)
Sep 164
Abate Kristin0001193125-25-205038
SEC(opens sec.gov)
Sep 44
Abate Kristin0002045943-25-000004
SEC(opens sec.gov)
Jul 234
Abate Kristin0000950170-25-097965
SEC(opens sec.gov)
Mar 64
Abate Kristin0000950170-25-034662
SEC(opens sec.gov)
Mar 44
Abate Kristin0000950170-25-032305
SEC(opens sec.gov)

Companies

Karyopharm Therapeutics Inc.Chief Accounting OfficerKPTI

Address

C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE

NEWTON, MA, 02459